GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Price-to-Operating-Cash-Flow

Aarti Drugs (BOM:524348) Price-to-Operating-Cash-Flow : (As of Apr. 29, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Price-to-Operating-Cash-Flow?

As of today (2024-04-29), Aarti Drugs's share price is ₹503.75. Aarti Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, Aarti Drugs's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Aarti Drugs's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOM:524348' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 3.37   Max: 66.62
Current: 34.76

During the past 13 years, Aarti Drugs's highest Price-to-Operating-Cash-Flow Ratio was 66.62. The lowest was 0.00. And the median was 3.37.

BOM:524348's Price-to-Operating-Cash-Flow is ranked worse than
75.3% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.435 vs BOM:524348: 34.76

Aarti Drugs's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₹0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -18.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 2.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.40% per year.

During the past 13 years, Aarti Drugs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.80% per year. The lowest was -20.60% per year. And the median was 9.90% per year.


Aarti Drugs Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Aarti Drugs's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Price-to-Operating-Cash-Flow Chart

Aarti Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.55 4.70 41.79 56.42 23.31

Aarti Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 23.31 - - -

Competitive Comparison of Aarti Drugs's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Price-to-Operating-Cash-Flow falls into.



Aarti Drugs Price-to-Operating-Cash-Flow Calculation

Aarti Drugs's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=503.75/0
=

Aarti Drugs's Share Price of today is ₹503.75.
Aarti Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Aarti Drugs Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines